AAL vs XXII

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

AAL

55.2
AI Score
VS
AAL Wins

XXII

45.2
AI Score

Investment Advisor Scores

AAL

55score
Recommendation
HOLD

XXII

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAL XXII Winner
Revenue 30.65B 20.36M AAL
Net Income -311.00M -10.61M XXII
Net Margin -1.0% -52.1% AAL
Operating Income 405.00M -9.86M AAL
ROE 7.8% -305.5% AAL
ROA -0.5% -40.5% AAL
Total Assets 64.23B 26.18M AAL
Cash 1.03B 5.34M AAL
Debt/Equity -6.36 2.02 AAL
Current Ratio 0.53 1.09 XXII

Relative Price Performance (Last 90 Days)

AAL 1M: -5.8% · 3M: -1.6% XXII 1M: -13.7% · 3M: +517.0%

Current Technical Phase

AAL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 36.8 · Price: $13.63

XXII

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.1 · Price: $3.68

Fundamentals Snapshot

Metric AAL XXII
Market Cap
Forward P/E 5.6 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.2% -0.4%
Gross Margin 0.2% -0.5%
Operating Margin 0.0% -2.5%
EPS -0.49 2314.46
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AAL is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.